Translating genetic determinants of glaucoma into better diagnosis and treatment

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1150144

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Glaucoma is the leading cause of irreversible blindness worldwide. By 2020, it will affect 80 million people, and in Australia over the next decade, the overall cost of glaucoma will reach $4.3 billion per annum. This Program will use genetic advances to personalise treatment. Blindness will be prevented in individuals at highest risk, new ways to treat patients will be developed, and better outcomes for patients will result from less treatment and monitoring of low risk cases.

Funded Activity Details

Start Date: 01-01-2019

End Date: 01-01-2023

Funding Scheme: Program Grants

Funding Amount: $9,466,000.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Vision Science

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

blindness | eye disease | glaucoma | treatment strategies | vision loss

Related Links